Skip to main content

Month: March 2020

Neos Therapeutics Reports Fourth Quarter and Year-End 2019 Financial Results

– Full year 2019 net revenues increased by 29% and operating loss decreased by $33M –– Neos RxConnect rapidly expanded with ~500 pharmacies in network at year-end –– NT0502 Phase 1 ascending dose trial initiation planned in 2H20 following top-line PK data –– Company to host conference call today at 8:30am ET –DALLAS and FORT WORTH, Texas, March 13, 2020 (GLOBE NEWSWIRE) — Neos Therapeutics, Inc. (Nasdaq: NEOS), a commercial-stage pharmaceutical company developing and manufacturing central nervous system-focused products, today reported financial results for the fourth quarter and fiscal year ended December 31, 2019 and provided a business update.“We made tremendous strides in 2019, following the reset of our commercial strategy for our ADHD portfolio, which resulted in an improvement to the financial foundation of the company. In...

Continue reading

Harrow Health Publishes Fourth Quarter 2019 Letter to Stockholders

NASHVILLE, Tenn., March 13, 2020 (GLOBE NEWSWIRE) — Harrow Health, Inc. (NASDAQ: HROW) today reported results for the fourth quarter 2019.  Please click here to review Harrow Health’s Letter to Stockholders for the fourth quarter 2019.Mark L. Baum, CEO of Harrow Health, commented, “During 2019, we plowed the ground for the next leg up for the company and our shareholders.  We own a powerful and valuable group of businesses, all with significant milestones expected in 2020.  Operationally, in Q4 we hit the ball out of the park on gross margin – delivering on our target a year ahead of schedule.  New equipment coming online in a few weeks and additional efficiencies we expect shortly should secure the gross margin targets we promised to deliver going forward.  We have numerous ways to meet or even exceed expectations on revenue and...

Continue reading

CORRECTION in appendix of interim condensed consolidated financial statements for the 12 months period ended 31 December 2019

On 28 February 2020 an announcement of Group’s 12 months 2019 financial results was made. During the design of the appendix several errors were made, incl. in financial data – in Profit for the reporting period 2018 (page 29), in section Property, plant and equipment (page 30), in section Non-current liabilities (page 31), in cash flow statement section Operating cash flows before working capital changes for 2019 (page 32), in statement of changes in equity in Share Premium column as at 31.12.2017. (page 33), in table Related party disclosures, line SIA Olmafarm as at 31.12.2019. in column Amounts owed by related parties (gross) (page 37), in table Segment information in line Segment profit before tax 12M 2019, column Unallocated and eliminated (page 38), in table Reconciliation of profit Unallocated financial income (page 38).Financial...

Continue reading

LABOTS pielikums ziņā par starpperioda saīsinātajā konsolidētajā finanšu pārskatā par 2019. gada 12 mēnešiem

Š.g. 28. februārī tika publicēta ziņa par Grupas 2019. gada 12 mēnešu finanšu rezultātiem. Pielikuma maketēšanas procesā ieviesās vairākas kļūdas, t.sk. finanšu datos – pārskata perioda peļņā par 2018. gadu (29.lpp.), sadaļā pamatlīdzekļi (30.lpp.), sadaļā ilgtermiņa kreditori (31.lpp.), naudas plūsmas pārskatā Saimnieciskās darbības peļņa pirms apgrozāmā kapitāla izmaiņām par 2019.gadu (32.lpp.), Pašu kapitāla izmaiņu pārskatā ailē Akciju emisijas uzcenojums uz 31.12.2017. (33.lpp.), tabulā Darījumu ar saistītajām personām, rindā SIA Olmafarm uz 31.12.2019. ailē Parādi saistītajām personām (bruto) (37.lpp.), tabulā Informācijas atspoguļošana par segmentiem, rindā Segmenta peļņa pirms nodokļiem 12M 2019, ailē Neattiecināts un izslēgts (38.lpp.), tabulā Peļņas salīdzinājums rindā Neattiecinātie finanšu ieņēmumi par 12M 2019 (38.lpp.).Ziņas...

Continue reading

HeadHunter Group PLC Announces Fourth Quarter and Full-Year 2019 Financial Results

MOSCOW, March 13, 2020 (GLOBE NEWSWIRE) — HeadHunter Group PLC (Nasdaq: HHR) announced today its financial results for the quarter and the full year ended December 31, 2019. As used below, references to “we,” “our,” “us” or the “Company” or similar terms shall mean HeadHunter Group PLC.Fourth Quarter 2019 Financial and Operational Highlights(1)  “RUB” or “₽” denote Russian Ruble throughout this release.(2)  “USD” or “$” denote U.S. Dollar throughout this release.(3)  Percentage movements and certain other figures in this release may not recalculate exactly due to rounding. This is because percentages and/or figures contained herein are calculated based on actual numbers and not the rounded numbers presented.(4)  Dollar translations are included solely for the convenience of the reader and were calculated at the exchange rate quoted...

Continue reading

THE TILE SHOP REPORTS FOURTH QUARTER 2019 RESULTS

MINNEAPOLIS, March 13, 2020 (GLOBE NEWSWIRE) — Tile Shop Holdings, Inc. (OTC Pink: TTSH) (the “Company”), a specialty retailer of natural stone and man-made tiles, setting and maintenance materials, and related accessories, today announced results for its fourth quarter ended December 31, 2019.Fourth Quarter SummaryNet Sales Decreased 6.4%Comparable Store Sales Decreased 6.6%Gross Margin of 68.4%Net Loss of $4.2 million; Adjusted EBITDA of $5.1 million(1) As compared to the prior year period.(2) Comparable store sales (decline) growth is the percentage change in sales of comparable stores period over period. A store is considered comparable on the first day of the 13th full month of operation. When a store is relocated, it is excluded from the comparable store sales (decline) growth calculation. Comparable store sales (decline)...

Continue reading

Foresight VCT plc – Intention to Utilise Over-Allotment Facility

FORESIGHT VCT PLC (Company)Announcement of Intention to Utilise Over-Allotment FacilityThe Board of Foresight VCT plc (the “Company“) is pleased to announce that the Company has received applications under the offer for subscription launched by the Company on 28 January 2020 (the “Offer“) approaching the original capacity of £20 million worth of new shares of 1p each in the capital of the Company (“Offer Shares”).The Board has now exercised its discretion to increase the size of the Offer by a further £5 million, in accordance with the prospectus issued by the Company on 28 January 2020 (the “Prospectus“).Full details of the Offer are contained in the Prospectus, which is available for download from the Company’s website (www.foresightvct.com) and the National Storage Mechanism (www.morningstar.co.uk/uk/nsm).For...

Continue reading

Tidal Provides Corporate Update

VANCOUVER, British Columbia , March 12, 2020 (GLOBE NEWSWIRE) — Tidal Royalty Corp. (CSE: RLTY.U |OTC: TDRYF) (“Tidal” or the “Company”) is pleased to provide an update further to the executed business combination agreement with MichiCann Medical Inc. (operating as Red White & Bloom) (“MichiCann”) (see our news release dated May 13, 2019).On March 12, 2020, the Company and MichiCann entered into an amended and restated business combination agreement (the “Amended Agreement”) pursuant to which the Company will acquire all of the issued and outstanding shares of MichiCann (the “Proposed Transaction”) on a 2:1 basis, subject to adjustment in certain circumstances (the “Exchange Ratio”). The terms of the Amended Agreement provide that the share consideration will now be comprised of one (1) common share (the “Common Shares”) and...

Continue reading

Savills Closes on Acquisition of Leading Project Management Firm Macro Consultants

New York, March 12, 2020 (GLOBE NEWSWIRE) — Savills has completed its acquisition of Macro Consultants LLC, a leading project management firm. The agreement accelerates the expansion of Savills existing advisory and management services platform while enhancing the firm’s ability to deliver tier-one project management and consulting solutions to its clients. Macro, led by its long-time owner Michael Glatt, has been recognized as one of the industry’s most successful and fastest-growing companies, with more than 85 professionals in New York, Los Angeles, Washington, D.C., Denver and Philadelphia. Macro serves as a trusted advisor to an impressive list of clients, from nonprofit organizations to Fortune 100 companies, to help budget and oversee a wide range of capital projects, including relocations, expansions, and modernizations. “I...

Continue reading

Communiqué Orange / Business & Decisions : dépôt d’un projet d’offre publique de retrait visant les actions de la société

COMMUNIQUE RELATIF AU DEPOT D’UN PROJET D’OFFRE PUBLIQUE DE RETRAIT VISANT LES ACTIONS DE LA SOCIETEBusiness & DécisionINITIÉE PAR ORANGE BUSINESS SERVICES, FILIALE DEOrangeET PRÉSENTÉE PARPortzamparc / BNP Paribas GroupEtablissement présentateur et garantPROJET DE NOTE D’INFORMATION ETABLI PAR ORANGE BUSINESS SERVICESPRIX D’OFFRE : 7,93 euros par action Business & DecisionDUREE DE L’OFFRE : 10 jours de négociationLe calendrier de la présente offre publique de retrait sera fixé par l’Autorité des marchés financiers (« AMF ») conformément à son règlement général.AMFLe présent communiqué relatif au dépôt d’un projet de note d’information a été établi et diffusé le 12 mars 2020 par Orange Business Services, conformément aux dispositions des articles 231-16 du règlement général de l’AMF.CETTE...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.